March 2025

Assessment of post adverse drug reactions outcome among people living with HIV/AIDS at level 3 health facilities in Nairobi County

The use of antiretroviral drugs (ARVs) in people living with HIV/AIDS (PLHIV) has led to the occurrence of adverse drug reactions (ADRs), which are defined by the WHO as any unintended or excessive response to a drug. ADRs are influenced by both the impact of the disease on the immune system and the safety profile of ARVs. Pharmacovigilance is crucial in identifying and preventing such ADRs. The present study aims to...

Author(s): Namazzi Jeniffer Adungosi, Eddy Odari, Christina Mwachari and Boaz Nyona Matende  

March 2025

Unveiling gender disparities and State dynamics in HIV viral suppression: Insights from Southern Nigeria

This study aimed to elucidate gender disparities and state dynamics in HIV viral suppression within the context of Southern Nigeria, as part of the USAID-funded project "Accelerating Control of the HIV/AIDS Epidemic in Nigeria, Cluster 6" (ACE 6). The study employed an ex post facto research design and used multiple logistic regressions to analyze patient-level data for active Peo ple Living with HIV (PLHIV)...

Author(s): Clifford A. Umeh, Oluwatosin T. Ogungbade, Omololuoye B. Majekodunmi, Bartholomew B. Ochonye, Ogonnaya G. Kanu-Oji, Blessing O. Airiagbonbu, John P. Mbah, Amaka Ezeadikwa, Nurudeen Agboola, Oluwatoyin Adegbite, Elijah Mmokutmfon, Obinna Chigbundu,  Okpanachi Momoh, Grace Omubo, Chidinma Chiekwe, Kalada Green, Onyeka Igboelina, Dolapo Ogundehin, Gbenga Asaolu, Chika Obiora-Okafo, Augustine Idemudia, Chukwuka Nwadike, Babatunde Oyawola, Betty Pius, Bayo Onimode,  Kunle Kakanfo, Kingston Omo-Emmanuel, Pamela Gado, Moses Katbi, David Onime, Ezekiel James, Jemeh Pius, Omosalewa Oyelaran, Adebobola Bashorun Temitope Ilori, Chukwuebuka Ejeckam and Blessing O. Airiagbonbu

March 2025

CD4 T-Lymphocytes, adherence and sociodemographic factors associated with viral load outcome of people living with HIV (PLHIV) on antiretroviral therapy in Lagos State, Nigeria

Globally, a significant number of people were living with HIV in 2022, with a substantial proportion receiving antiretroviral therapy (ART). Despite these advancements, HIV continues to pose a serious challenge to global health. Against this backdrop, this study evaluated CD4 T-lymphocytes, adherence, and sociodemographic factors associated with the current viral load outcome of People Living with HIV (PLHIV) on ART in...

Author(s): Oluwatosin Temitope Ogungbade, Clifford Umeh, Omololuoye Majekodunmi, Ogonnaya Kanu-Oji, John Paul Mbah, Bartholomew Ochonye Kalada Green Elijah Mmokutmfon, Obinna Chigbundu, Onyeka Igboelina, Dolapo Ogundehin, Gbenga Asaolu, Chika Obiora-Okafo, Augustine Idemudia, Chukwuka Nwadike, Babatunde Oyawola, Bayo Onimode, Betty Pius, Kunle Kakanfo, Pamela Gado, Moses Katbi, David Onime, Ezekiel James, Jameh Pius, Omosalewa Oyelaran, Adebobola Bashorun, Temitope Ilori, Kingston Omo-Emmanuel Okpanachi Momoh and Chukwuebuka Ejeckam.  

June 2025

Prevalence and risk factor of renal dysfunction among HIV patients on highly active antiretroviral therapy at the Buea Regional Hospital: A cross-sectional study in Cameroon

Renal dysfunction is a significant global health issue, with varying prevalence across populations. In Africa, 2 to 41% of the general population and 11 to 25% of people living with HIV (PLHIV) experienced renal dysfunction in 2022. This study aimed to assess the prevalence and risk factors of renal dysfunction among HIV patients on highly active antiretroviral therapy (HAART) at the Buea Regional Hospital. This was a...

Author(s): Ghislain Dema, Divine Enoru Eyongeta, Cyril Kamadjou, Takamo Peter, Enoh Junior Enoh and Ngende Rosine Nyake